Clinical trial
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of…
NCT00287534 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00287534 |
|---|---|
| Title | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. |
| Official title | A Prospective, Multi-Centre, Randomised, Open Parallel Group Study to Compare the Effectiveness and Compatibility of ARIMIDEX (ZD 1033) With NOLVADEX After a Prior 2 Years' Treatment With Tamoxifen in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. |
| Acronym | ARNO-95 |
| Lead sponsor | AstraZeneca, Industry |
| Collaborators | German Adjuvant Breast Cancer Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Anastrozole, Tamoxifen |
| Enrollment | 1,059 |
| Start date | Nov 1, 1996 |
| Completion | Sep 1, 2004 |
| First posted | Feb 7, 2006 |
| Last update posted | Jun 9, 2009 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: